Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China
· Delayed Price · Currency is CNY 15.60
+0.21 (1.36%)
Mar 10, 2026, 3:04 PM CST
SHE:300401 Revenue
Zhejiang Garden Biopharmaceutical had revenue of 300.34M CNY in the quarter ending September 30, 2025, a decrease of -10.99%. This brings the company's revenue in the last twelve months to 1.24B, up 9.43% year-over-year. In the year 2024, Zhejiang Garden Biopharmaceutical had annual revenue of 1.24B with 13.58% growth.
Revenue (ttm)
1.24B
Revenue Growth
+9.43%
P/S Ratio
6.74
Revenue / Employee
1.22M
Employees
1,021
Market Cap
8.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.24B | 148.63M | 13.58% |
| Dec 31, 2023 | 1.09B | -322.86M | -22.78% |
| Jan 1, 2023 | 1.42B | 300.41M | 26.89% |
| Jan 1, 2022 | 1.12B | 457.66M | 69.40% |
| Dec 31, 2020 | 659.44M | -58.95M | -8.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hunan Er-Kang Pharmaceutical | 1.29B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| China Animal Husbandry Industry | 6.28B |
| PharmaBlock Sciences (Nanjing) | 1.98B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Hubei Hongyuan Pharmaceutical Technology | 1.77B |